Latanoprost Sandoz (Latanoprost)

Latanoprost binds to FP receptors in the eye’s ciliary body, increasing the uveoscleral outflow of aqueous humor. This enhanced outflow reduces intra‑ocular pressure, which is the primary therapeutic goal in glaucoma and ocular hypertension management.

The dosing regimen for Latanoprost Sandoz is determined by the prescribing clinician based on the patient’s condition and response. Typically, one drop is instilled into the affected eye(s) once daily in the evening, but exact instructions must come from a qualified eye‑care professional.

The safety of Latanoprost Sandoz in pregnancy and lactation has not been definitively established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made in consultation with a healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Latanoprost belongs to the prostaglandin analog class, which generally offers once‑daily dosing and strong IOP‑lowering efficacy. Compared with beta‑blocker or carbonic anhydrase inhibitor drops, prostaglandin analogs often achieve greater pressure reduction with a convenient dosing schedule, though individual response may vary.

Latanoprost Sandoz should be stored at room temperature, below 25 °C, in its original container. Protect the solution from light and moisture, and keep it out of reach of children. Do not freeze the product.

Latanoprost Sandoz is administered as an eye drop. The patient should wash their hands, tilt the head back, pull down the lower eyelid to create a pocket, and place a single drop into the conjunctival sac of the affected eye(s) once daily, usually in the evening.

Serious risks, though rare, include severe eye pain, sudden loss of vision, allergic reactions such as eyelid swelling, uveitis, and corneal edema. Patients should seek immediate medical attention if they experience any of these symptoms.

Latanoprost Sandoz should be avoided in patients with active ocular inflammation, known hypersensitivity to latanoprost or any component of the formulation, and in those where prostaglandin analogs are contraindicated. A healthcare professional must evaluate suitability before prescribing.